3 Profitable Stocks with Open Questions
Dataset grows to more than 312,000 whole genomes with longitudinal clinical data
Increased adoption of clinical whole-genome sequencing is advancing diagnostics for rare diseases, which affect 15 million American children
SAN DIEGO , Feb. 26, 2026 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a suite of powerful advancements that will...
At AGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutions
SAN DIEGO , Feb. 24, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced the launch of TruPath™ Genome, setting a new standard for high-quality, comprehensive whole genome insights...
40% increase in output to 35 billion reads, up to Q70 quality scores, improved turnaround time, and staggered starts are among the updates to be rolled out on all NovaS eq X systems , advancing...
SAN DIEGO , Feb. 17, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that members of its management team will participate at the following investor conference:
1 Healthcare Stock Worth Your Attention and 2 Facing Challenges
5 Insightful Analyst Questions From Illumina’s Q4 Earnings Call